Provided by Tiger Trade Technology Pte. Ltd.

China SXT Pharmaceuticals

2.22
0.0000
Volume:19.33K
Turnover:44.19K
Market Cap:1.19M
PE:0.00
High:2.35
Open:2.24
Low:2.22
Close:2.22
52wk High:83,758.80
52wk Low:2.06
Shares:533.98K
Float Shares:530.60K
Volume Ratio:1.00
T/O Rate:3.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-730.3881
EPS(LYR):-185.6895
ROE:-27.49%
ROA:-15.78%
PB:0.04
PE(LYR):-0.01

Loading ...

May 30, 2019

Public Prospectus

Registration statement for certain foreign private issuers
May 03, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 17, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 28, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 27, 2018

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Sep 26, 2018

Correspondence

[Cover]Correspondence
Sep 26, 2018

Correspondence

[Cover]Correspondence
Sep 17, 2018

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers
Sep 17, 2018

Correspondence

[Cover]Correspondence
Aug 17, 2018

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers
Jun 07, 2018

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
May 07, 2018

Correspondence

[Cover]Correspondence
May 07, 2018

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers
Apr 20, 2018

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers
Apr 20, 2018

Correspondence

[Cover]Correspondence
Mar 28, 2018

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers
Mar 28, 2018

Correspondence

[Cover]Correspondence
Mar 06, 2018

Correspondence

[Cover]Correspondence
Mar 06, 2018

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers
Jan 19, 2018

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers